Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global NK Cell Therapy Industry market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
NK Cell Therapy Industry market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The NK Cell Therapy Industry market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the NK Cell Therapy Industry products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of NK Cell Therapy Industry products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the NK Cell Therapy Industry market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on NK Cell Therapy Industry development has been the leading industry trend of NK Cell Therapy Industry market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global NK Cell Therapy Industry Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
NK Cell Therapies, NK Cell Directed Antibodies, Other |
| By Application Outlook |
Cancer, Gastrointestinal Diseases, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Nektar Therapeutics
- Innate Pharma SA
- Affimed
- Chipscreen Biosciences
- Fate Therapeutics
- Glycostem Therapeutics
- Dragonfly Therapeutics
- Kiadis Pharma
- NantWorks
- Nkarta Therapeutics
- Fortress Biotech
NK Cell Therapy Industry Market, By Type
- NK Cell Therapies
- NK Cell Directed Antibodies
- Other
NK Cell Therapy Industry Market, By Application
- Cancer
- Gastrointestinal Diseases
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global NK Cell Therapy Industry Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 NK Cell Therapy Industry Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 NK Cell Therapies Sales (K Units), Revenue (M USD) and Growth Rate 2015-2020
2.2 NK Cell Directed Antibodies Sales (K Units), Revenue (M USD) and Growth Rate 2015-2020
3 Asia Pacific NK Cell Therapy Industry Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America NK Cell Therapy Industry Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe NK Cell Therapy Industry Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America NK Cell Therapy Industry Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa NK Cell Therapy Industry Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World NK Cell Therapy Industry Market Assessment by Type
8.1 Asia Pacific NK Cell Therapy Industry Market Assessment by Application (Consumption and Market Share)
8.2 North America NK Cell Therapy Industry Market Assessment by Application (Consumption and Market Share)
8.3 Europe NK Cell Therapy Industry Market Assessment by Application (Consumption and Market Share)
8.4 South America NK Cell Therapy Industry Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa NK Cell Therapy Industry Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Nektar Therapeutics
9.1.1 Nektar Therapeutics Profiles
9.1.2 Nektar Therapeutics Product Portfolio
9.1.3 Nektar Therapeutics NK Cell Therapy Industry Business Performance
9.1.4 Nektar Therapeutics NK Cell Therapy Industry Business Development and Market Status
9.2 Innate Pharma SA
9.2.1 Innate Pharma SA Profiles
9.2.2 Innate Pharma SA Product Portfolio
9.2.3 Innate Pharma SA NK Cell Therapy Industry Business Performance
9.2.4 Innate Pharma SA NK Cell Therapy Industry Business Development and Market Status
9.3 Affimed
9.3.1 Affimed Profiles
9.3.2 Affimed Product Portfolio
9.3.3 Affimed NK Cell Therapy Industry Business Performance
9.3.4 Affimed NK Cell Therapy Industry Business Development and Market Status
9.4 Chipscreen Biosciences
9.4.1 Chipscreen Biosciences Profiles
9.4.2 Chipscreen Biosciences Product Portfolio
9.4.3 Chipscreen Biosciences NK Cell Therapy Industry Business Performance
9.4.4 Chipscreen Biosciences NK Cell Therapy Industry Business Development and Market Status
9.5 Fate Therapeutics
9.5.1 Fate Therapeutics Profiles
9.5.2 Fate Therapeutics Product Portfolio
9.5.3 Fate Therapeutics NK Cell Therapy Industry Business Performance
9.5.4 Fate Therapeutics NK Cell Therapy Industry Business Development and Market Status
9.6 Glycostem Therapeutics
9.6.1 Glycostem Therapeutics Profiles
9.6.2 Glycostem Therapeutics Product Portfolio
9.6.3 Glycostem Therapeutics NK Cell Therapy Industry Business Performance
9.6.4 Glycostem Therapeutics NK Cell Therapy Industry Business Development and Market Status
9.7 Dragonfly Therapeutics
9.7.1 Dragonfly Therapeutics Profiles
9.7.2 Dragonfly Therapeutics Product Portfolio
9.7.3 Dragonfly Therapeutics NK Cell Therapy Industry Business Performance
9.7.4 Dragonfly Therapeutics NK Cell Therapy Industry Business Development and Market Status
9.8 Kiadis Pharma
9.8.1 Kiadis Pharma Profiles
9.8.2 Kiadis Pharma Product Portfolio
9.8.3 Kiadis Pharma NK Cell Therapy Industry Business Performance
9.8.4 Kiadis Pharma NK Cell Therapy Industry Business Development and Market Status
9.9 NantWorks
9.9.1 NantWorks Profiles
9.9.2 NantWorks Product Portfolio
9.9.3 NantWorks NK Cell Therapy Industry Business Performance
9.9.4 NantWorks NK Cell Therapy Industry Business Development and Market Status
9.10 Nkarta Therapeutics
9.10.1 Nkarta Therapeutics Profiles
9.10.2 Nkarta Therapeutics Product Portfolio
9.10.3 Nkarta Therapeutics NK Cell Therapy Industry Business Performance
9.10.4 Nkarta Therapeutics NK Cell Therapy Industry Business Development and Market Status
9.11 Fortress Biotech
10 World NK Cell Therapy Industry Market Assessment by Players
10.1 Global NK Cell Therapy Industry Sales (K Units) and Market Share by Players 2015-2020
10.2 Global NK Cell Therapy Industry Revenue (M USD) and Market Share by Players 2015-2020
10.3 Global NK Cell Therapy Industry Price (USD/Unit) of Players 2015-2020
10.4 Global NK Cell Therapy Industry Gross Margin of Players 2015-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America NK Cell Therapy Industry Sales Assessment of Players 2015-2020
11.1.2 North America NK Cell Therapy Industry Revenue Assessment of Players 2015-2020
11.1.3 North America NK Cell Therapy Industry Price Assessment of Players 2015-2020
11.1.4 North America NK Cell Therapy Industry Gross Margin Assessment of Players 2015-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe NK Cell Therapy Industry Sales Assessment of Players 2015-2020
11.2.2 Europe NK Cell Therapy Industry Revenue Assessment of Players of Manufacturers 2015-2020
11.2.3 Europe NK Cell Therapy Industry Price Assessment of Players 2015-2020
11.2.4 Europe NK Cell Therapy Industry Gross Margin Assessment of Players 2015-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific NK Cell Therapy Industry Sales Assessment of Players 2015-2020
11.3.2 Asia-Pacific NK Cell Therapy Industry Revenue Assessment of Players 2015-2020
11.3.3 Asia-Pacific NK Cell Therapy Industry Price Assessment of Players 2015-2020
11.3.4 Asia-Pacific NK Cell Therapy Industry Gross Margin Assessment of Players 2015-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America NK Cell Therapy Industry Sales Assessment of Players 2015-2020
11.4.2 South America NK Cell Therapy Industry Revenue Assessment of Players 2015-2020
11.4.3 South America NK Cell Therapy Industry Price Assessment of Players 2015-2020
11.4.4 South America NK Cell Therapy Industry Gross Margin Assessment of Players 2015-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa NK Cell Therapy Industry Sales Assessment of Players 2015-2020
11.5.2 Middle East and Africa NK Cell Therapy Industry Revenue Assessment of Players 2015-2020
11.5.3 Middle East and Africa NK Cell Therapy Industry Price Assessment of Players 2015-2020
11.5.4 Middle East and Africa NK Cell Therapy Industry Gross Margin Assessment of Players 2015-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific NK Cell Therapy Industry Sales by Countries/Regions 2015-2020
12.1.2 Asia Pacific NK Cell Therapy Industry Revenue by Countries/Regions 2015-2020
12.1.3 Asia Pacific NK Cell Therapy Industry Average Price by Countries/Regions 2015-2020
12.2 North America
12.2.1 North America NK Cell Therapy Industry Sales by Countries/Regions 2015-2020
12.2.2 North America NK Cell Therapy Industry Revenue by Countries/Regions 2015-2020
12.2.3 North America NK Cell Therapy Industry Average Price by Countries/Regions 2015-2020
12.3 Europe
12.3.1 Europe NK Cell Therapy Industry Sales by Countries/Regions 2015-2020
12.3.2 Europe NK Cell Therapy Industry Revenue by Countries/Regions 2015-2020
12.3.3 Europe NK Cell Therapy Industry Average Price by Countries/Regions 2015-2020
12.4 South America
12.4.1 South America NK Cell Therapy Industry Sales by Countries/Regions 2015-2020
12.4.2 South America NK Cell Therapy Industry Revenue by Countries/Regions 2015-2020
12.4.3 South America NK Cell Therapy Industry Average Price by Countries/Regions 2015-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa NK Cell Therapy Industry Sales by Countries/Regions 2015-2020
12.5.2 Middle East and Africa NK Cell Therapy Industry Revenue by Countries/Regions 2015-2020
12.5.3 Middle East and Africa NK Cell Therapy Industry Average Price by Countries/Regions 2015-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World NK Cell Therapy Industry Sales & Revenue Forecast 2021-2026
14.1 World NK Cell Therapy Industry Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World NK Cell Therapy IndustrySales and Market Share by Regions
14.1.2 World NK Cell Therapy IndustryRevenue and Market Share by Regions
15 Asia NK Cell Therapy Industry Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 NK Cell Therapies
15.1.2 NK Cell Directed Antibodies
15.2 Consumption Forecast by Application, 2021-2026
16 North America NK Cell Therapy Industry Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 NK Cell Therapies
16.1.2 NK Cell Directed Antibodies
16.2 Consumption Forecast by Application, 2021-2026
17 Europe NK Cell Therapy Industry Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 NK Cell Therapies
17.1.2 NK Cell Directed Antibodies
17.2 Consumption Forecast by Application, 2021-2026
18 South America NK Cell Therapy Industry Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 NK Cell Therapies
18.1.2 NK Cell Directed Antibodies
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa NK Cell Therapy Industry Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 NK Cell Therapies
19.1.2 NK Cell Directed Antibodies
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global NK Cell Therapy Industry Price (USD/Unit) Trend 2021-2026
20.2 Global NK Cell Therapy Industry Gross Profit Trend 2021-2026
21 Conclusion
